[[abstract]]Combinational drug treatment has the potential of improving treatment efficacy, reducing side effects and minimizing resistance. In this work, we present a device for performing combinatorial drug screening on 3D-cultured cells in a microfluidic portable device which has the potential to be used for testing drug response of cancer patients for personalized medicine. The device utilizes a normally closed pneumatic valve system to operate an array of 8 x 8 individual drug testing chambers. This allows for easy generation of mimicking cell culture conditions for screening potential combinatorial drugs at reduced cost and minimal sample consumption
The development and application of miniaturized platforms with the capability for microscale and dyn...
In the last few decades, drug combination therapy has been widely applied in oncology and in other c...
Microfluidic devices present unique advantages for the development of efficient drug carrier particl...
[[abstract]]Combinational drug treatment has the potential of improving treatment efficacy, reducing...
[[abstract]]In vitro testing of drug compounds on cell models during the drug development process re...
We present the development of a three-dimensional (3-D) combinatorial cell culture array device feat...
\u3cp\u3eScreening drugs on patient biopsies from solid tumours has immense potential, but is challe...
For treating cancer at various stages, chemotherapy drugs administered in combination provide better...
Screening for potential drug combinations presents significant challenges to the current microfluidi...
Microfluidics-based drug-screening systems have enabled efficient and high-throughput drug screening...
Traditional high-throughput drug combination screening requires automatic pipetting of drugs into hi...
We performed cell-based drug combination screening using an integrated droplet-based microfluidic sy...
Despite recent advances in immunotherapies for lung cancer, their success is still hindered by limit...
The development and application of miniaturized platforms with the capability for microscale and dyn...
In the last few decades, drug combination therapy has been widely applied in oncology and in other c...
Microfluidic devices present unique advantages for the development of efficient drug carrier particl...
[[abstract]]Combinational drug treatment has the potential of improving treatment efficacy, reducing...
[[abstract]]In vitro testing of drug compounds on cell models during the drug development process re...
We present the development of a three-dimensional (3-D) combinatorial cell culture array device feat...
\u3cp\u3eScreening drugs on patient biopsies from solid tumours has immense potential, but is challe...
For treating cancer at various stages, chemotherapy drugs administered in combination provide better...
Screening for potential drug combinations presents significant challenges to the current microfluidi...
Microfluidics-based drug-screening systems have enabled efficient and high-throughput drug screening...
Traditional high-throughput drug combination screening requires automatic pipetting of drugs into hi...
We performed cell-based drug combination screening using an integrated droplet-based microfluidic sy...
Despite recent advances in immunotherapies for lung cancer, their success is still hindered by limit...
The development and application of miniaturized platforms with the capability for microscale and dyn...
In the last few decades, drug combination therapy has been widely applied in oncology and in other c...
Microfluidic devices present unique advantages for the development of efficient drug carrier particl...